TKR

The Timken Company

Stock · NYSE

Program summary

FieldValueAs ofSource
Current authorization$1.0bnEST30-Sep-2610-Q filed 04-Nov-26
Remaining authorization$949mEST30-Sep-2610-Q filed 04-Nov-26
Program expiry28-Feb-3130-Sep-2610-Q filed 04-Nov-26
Repurchased last quarter$63m30-Sep-2610-Q filed 04-Nov-26
Has used an ASRNo—

Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.

Programs

Authorized onAuthorizedRemainingExpiresTerms
13-Feb-26$1.0bnEST
10.0m sh
$949mEST
9.1m sh left
28-Feb-31On February 13, 2026, the Company announced that its Board of Directors approved a new share repurchase plan, effective March 1, 2026, pursuant to which the Company may purchase up to ten million of its common shares, in the aggregate. This share purchase plan expires on February 28, 2031.10-Q filed 04-Nov-26

Open-market repurchases

Repurchased per month, USD (≈ shares × average price)
  1. Apr ’26
  2. May ’26
  3. Jun ’26
  4. Jul ’26
  5. Aug ’26
  6. ≈$29m
    Sep ’26
Month endedSharesWithheld & otherAvg price≈ ValueSource
30-Sep-26243,00016,084$118.30$29m10-Q filed 04-Nov-26
31-Aug-26160,539—$127.08$20m10-Q filed 04-Nov-26
31-Jul-26100,697127$139.10$14m10-Q filed 04-Nov-26
30-Jun-26105,582968$136.65$14m10-Q filed 04-Aug-26
Filings through 30-Sep-26· checked 18-Nov-26